A Multinational Randomized Double Blind Study Comparing Aflibercept Versus Placebo in Patients Treated with Second Line Docetaxel after Failure of One Platinum Based Therapy or Locally Advanced or Metastatic Non Small Cell Lung Cancer EFC10261